Loading clinical trials...
Loading clinical trials...
A Study of Bevacizumab, a Humanized Monoclonal Antibody Against Vascular Endothelial Growth Factor (VEGF), in Combination With Chemotherapy for Treatment of Osteosarcoma
Conditions
Interventions
Bevacizumab
Cisplatin
+6 more
Locations
5
United States
Rady Children's Hospital and Health Center
San Diego, California, United States
Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
NCI/NIH - Pediatric Oncology Branch
Bethesda, Maryland, United States
St Jude Children's Research Hospital
Memphis, Tennessee, United States
MD Anderson Cancer Center
Houston, Texas, United States
Start Date
June 3, 2008
Primary Completion Date
August 1, 2014
Completion Date
August 1, 2017
Last Updated
August 7, 2023
NCT07479732
NCT07144254
NCT06541262
NCT05235165
NCT04851119
NCT04698785
Lead Sponsor
St. Jude Children's Research Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions